Abstract: An insulator composition includes Al2O3 having a particle size of 120 to 500 nm. The insulator composition has a strength of 400 to 740 MPa and a particle size of 1 ?m or less.

Abstract: A multilayer ceramic capacitor includes: a body including dielectric layers and first and second internal electrodes alternately disposed with respective dielectric layers interposed therebetween; and first and second external electrodes disposed on the body and connected to the first and second internal electrodes, respectively, wherein the body includes first dummy patterns formed adjacent to the first internal electrodes in a width direction to be spaced apart from the first internal electrodes, and the first dummy patterns are stacked to partially overlap the second internal electrodes.

Abstract: A multilayer ceramic capacitor includes a ceramic body including an active portion including dielectric layers and internal electrodes that are alternately stacked and a margin portion disposed on outer surfaces of the active portion; and external electrodes disposed on outer surfaces of the ceramic body. The margin portion includes an inner half adjacent to the active portion and an outer half adjacent to the edge of the ceramic body, and a porosity of the inner half is greater than a porosity of the outer half.

Abstract: The present invention relates to a composition for preventing or treating asthma comprising a Pistacia weinmannifolia J. Poiss. ex Franch extract or a fraction thereof. The Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, the Pistacia weinmannifolia J. Poiss.

Abstract: A pharmaceutical composition includes any of an extract of Magnoliae flos, a fraction or an active fraction obtained by fractionation thereof with an organic solvent, and a compound separated therefrom as an active ingredient. The extract of Magnoliae flos, the fraction or the active fraction obtained by fractionation thereof with an organic solvent, or the compound separated therefrom inhibits the expression of MUC5AC induced by TNF-? and the promoter activity in human lung cancer mucosal cells (H292), reduces the number of inflammatory cells in the bronchoalveolar lavage fluid of the chronic obstructive pulmonary disease mouse model, inhibits the production of reactive oxygen species, and reduces the cytokines; and therefore are effective in preventing or treating chronic obstructive pulmonary disease.

Abstract: A multilayer ceramic capacitor includes a ceramic body including an active portion including dielectric layers and internal electrodes that are alternately stacked and a margin portion disposed on outer surfaces of the active portion; and external electrodes disposed on outer surfaces of the ceramic body. The margin portion includes an inner half adjacent to the active portion and an outer half adjacent to the edge of the ceramic body, and a porosity of the inner half is greater than a porosity of the outer half.

Abstract: A welding wire for high-strength steel disclosure comprises, in terms of wt % relative to the total weight thereof, C: 0.09-0.11%, Mn: 0.2-0.4%, Si: 0.3-0.65%, Al: 0.03-0.04%, S: 0.05-0.07%, Se: 0.005-0.01%, with Fe and other impurities comprising the balance.

Abstract: The present invention relates to a conductive polyamide/polyphenylene ether resin composition and an automotive molded article manufactured therefrom. The conductive polyamide/polyphenylene ether resin composition comprises: (a) a base resin comprising (a-1) polyphenylene ether and (a-2) polyamide; (b) a modified polyolefin based resin; (c) an impact modifier; (d) a compatibilizer; and (e) a conductive filler, and the conductive polyamide/polyphenylene ether resin composition is formed in a domain phase and a matrix phase, wherein the domain phase comprises (a-1) the polyphenylene ether and (c) the impact modifier and the matrix phase comprises (a-2) the polyamide and (b) the modified polyolefin based resin, (e) the conductive filler being dispersed on the domain phase and the matrix phase and the content of the conductive filler dispersed on the matrix phase being higher than that of the conductive filler dispersed on the domain phase.

Abstract: A multilayer ceramic electronic component includes a ceramic body in which dielectric layers and internal electrodes are alternately disposed. Ceramic-metal compound layers are disposed on interfaces between the internal electrodes and the dielectric layers. Additionally, in some examples, spaces between adjacent internal electrodes are fully occupied by the dielectric layers and the dielectric layers contain a ceramic-metal compound containing metal particle. The ceramic-metal compound layer may have an embossing type configuration or a dendrite type configuration.

Abstract: A method of manufacturing a multilayer ceramic electronic component includes forming external electrodes on end surfaces of a ceramic body, and more particularly, to forming external electrodes by attaching a sheet for forming an external electrode on a ceramic body. A multilayer ceramic electronic component thus formed has external electrodes with a thin and uniform thickness.

Abstract: A multilayer ceramic capacitor includes: a body including dielectric layers and first and second internal electrodes alternately disposed with respective dielectric layers interposed therebetween; and first and second external electrodes disposed on the body and connected to the first and second internal electrodes, respectively, wherein the body includes first dummy patterns formed adjacent to the first internal electrodes in a width direction to be spaced apart from the first internal electrodes, and the first dummy patterns are stacked to partially overlap the second internal electrodes.

Abstract: A multilayer ceramic capacitor includes: a ceramic body having dielectric layers laminated in a thickness direction, the dielectric layers having a greater width than a length; an active layer in which capacitance is formed, by including first and second internal electrodes alternately exposed to end surfaces of the ceramic body opposite to each other in a length direction with the dielectric layer interposed therebetween; upper cover layer; lower cover layers being thicker than the upper cover layer; and first and second external electrodes, wherein, when half of thickness of the ceramic body is denoted by A, thickness of the lower cover layer is denoted by B, half of thickness of the active layer is denoted by C, and thickness of the upper cover layer is denoted by D, 1.042?(B+C)/A?1.537 is satisfied.

Abstract: The present invention relates to a conductive polyamide/polyphenylene ether resin composition and an automotive molded article manufactured therefrom. The conductive polyamide/polyphenylene ether resin composition comprises: (a) a base resin comprising (a-1) polyphenylene ether and (a-2) polyamide; (b) a modified polyolefin based resin; (c) an impact modifier; (d) a compatibilizer; and (e) a conductive filler, and the conductive polyamide/polyphenylene ether resin composition is formed in a domain phase and a matrix phase, wherein the domain phase comprises (a-1) the polyphenylene ether and (c) the impact modifier and the matrix phase comprises (a-2) the polyamide and (b) the modified polyolefin based resin, (e) the conductive filler being dispersed on the domain phase and the matrix phase and the content of the conductive filler dispersed on the matrix phase being higher than that of the conductive filler dispersed on the domain phase.

Abstract: Disclosed herein is a thin film type capacitor element, including: a body part formed by stacking a plurality of dielectric layers; a first internal electrode provided in the body part and including a first non-plated region; a second internal electrode including a second non-plated region; a first via formed in the first non-plated region; and a second via formed in the second non-plated region.

Abstract: The present invention relates to a polyamide/polyphenylene ether resin composition containing: a base resin comprising polyphenylene ether, a polyamide and an impact modifier; a compatibilizer; and a polyamine, and to: a polyamide/polyphenylene ether resin composition having a notched Izod impact strength of about 12 kJ/m2 or more when measured at 23° C. according to the ISO 180 standard, and a number of checkerboard lattices, in which peeling off occurs, being about 5% or less of the total number of checkerboard lattices in a 1 mm-gap checkerboard pattern test for testing adhesion to acrylic paints and a melamine-based paints according to the JIS K5600-5-6 standard; and a preparation method therefor.

Abstract: A composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic response through various in vivo tests as well as in vitro test. Therefore, it can be used as the therapeutics or functional health food for treating and preventing chronic obstructive pulmonary disease (COPD).

Abstract: A pharmaceutical composition includes any of an extract of Magnoliae flos, a fraction or an active fraction obtained by fractionation thereof with an organic solvent, and a compound separated therefrom as an active ingredient. The extract of Magnoliae flos, the fraction or the active fraction obtained by fractionation thereof with an organic solvent, or the compound separated therefrom inhibits the expression of MUC5AC induced by TNF-? and the promoter activity in human lung cancer mucosal cells (H292), reduces the number of inflammatory cells in the bronchoalveolar lavage fluid of the chronic obstructive pulmonary disease mouse model, inhibits the production of reactive oxygen species, and reduces the cytokines; and therefore are effective in preventing or treating chronic obstructive pulmonary disease.

Abstract: Provided is a memory device including a delay circuit having gate insulation films with thicknesses different from each other. The memory device includes a delay circuit configured to input an input signal and output an output signal, and circuit blocks configured to control an operation of reading or writing memory cell data in response to the input signal or the output signal. One of transistors constituting a circuit block has a gate insulation film having such a thickness that an effect of negative biased temperature instability (NBTI) or positive biased temperature instability (PBTI) on the transistors is minimized. The delay circuit may be affected little by a shift in a threshold voltage that may be caused by NTBI or PBTI, and thus, achieve target delay time.

Abstract: An electrically conductive polyamide/polyphenylene ether resin composition and a molded article for vehicles using the same. The resin composition includes a polyphenylene ether; a polyamide; an olefin-based polymer; an impact modifier; a compatibilizer; and carbon fibrils, wherein the polyphenylene ether and the impact modifier form domains, and the polyamide, the olefin-based polymer and the carbon fibrils form a matrix, the domains including about 90 vol % or more of domain particles having a particle diameter of about 0.1 ?m to about 2.0 ?m, and wherein the electrically conductive polyamide/polyphenylene ether resin composition has a surface resistance of about 108?/? or less as measured on a specimen having a size of about 100 mm×about 100 mm×about 0.5 mm under conditions of about 23° C. and about 50% relative humidity (RH).

Abstract: The present invention relates to a novel 2-phenylbenzofuran derivative or a pharmaceutically acceptable salt thereof, a production method for the same, and a pharmaceutical composition for preventing or treating an inflammatory disease comprising the same as an active ingredient, and the novel 2-phenylbenzofuran derivative or the pharmaceutically acceptable salt thereof according to the present invention is outstandingly effective in suppressing NO, IL-6, and TNF-alpha induced by macrophages, and therefore can advantageously be used in a pharmaceutical composition for preventing or treating an inflammatory disease.